Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Short-term Investments (2022 - 2025)

Historic Short-term Investments for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $8575.5.

  • Addex Therapeutics' Short-term Investments rose 5021.8% to $8575.5 in Q3 2025 from the same period last year, while for Sep 2025 it was $8575.5, marking a year-over-year increase of 5021.8%. This contributed to the annual value of $7384.0 for FY2024, which is 68203.93% up from last year.
  • According to the latest figures from Q3 2025, Addex Therapeutics' Short-term Investments is $8575.5, which was up 5021.8% from $8448.0 recorded in Q2 2025.
  • Over the past 5 years, Addex Therapeutics' Short-term Investments peaked at $18622.3 during Q2 2023, and registered a low of $482.3 during Q3 2023.
  • For the 4-year period, Addex Therapeutics' Short-term Investments averaged around $5837.0, with its median value being $4456.6 (2023).
  • Per our database at Business Quant, Addex Therapeutics' Short-term Investments tumbled by 8490.17% in 2023 and then skyrocketed by 108365.03% in 2024.
  • Addex Therapeutics' Short-term Investments (Quarter) stood at $3285.3 in 2022, then tumbled by 70.9% to $956.0 in 2023, then soared by 675.66% to $7415.3 in 2024, then grew by 15.65% to $8575.5 in 2025.
  • Its last three reported values are $8575.5 in Q3 2025, $8448.0 for Q2 2025, and $7594.4 during Q1 2025.